Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review

Immune checkpoint inhibitors (ICIs) are an important advancement in the field of cancer treatment, significantly improving the survival of patients with a series of advanced malignancies, like melanoma, non-small cell lung cancer (NSCLC), hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cozma, Angela, Sporis, Nicolae Dan, Lazar, Andrada Luciana, Buruiana, Andrei, Ganea, Andreea Maria, Malinescu, Toma Vlad, Berechet, Bianca Mihaela, Fodor, Adriana, Sitar-Taut, Adela Viviana, Vlad, Vasile Calin, Negrean, Vasile, Orasan, Olga Hilda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502843/
https://www.ncbi.nlm.nih.gov/pubmed/36142866
http://dx.doi.org/10.3390/ijms231810948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502843/
https://www.ncbi.nlm.nih.gov/pubmed/36142866
http://dx.doi.org/10.3390/ijms231810948

Ejemplares similares